Inti Fernandez
General Practice · Miami, FLNPI 1659461101
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $711 of the $801 with a category attached, or 88.8%. 13 manufacturers reported payments, led by Abiomed at 26.9% of the total. Reporting peaked in 2024 at $406 and has fallen 74.3% since, to $104 in 2025.
Across 33 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$215
- AstraZeneca$140
- Astellas Pharma US Inc$90
- Amgen$78
- Novo Nordisk$66
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$47
- plus $165 from 7 others
Across 318 payments — averaging $4442.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$990K
- Ironwood Pharmaceuticals, Inc$238K
- Ardelyx, Inc.$111K
- Regeneron$44K
- Sun Pharmaceutical Industries Inc.$15K
- Cue Health Inc.$9K
- plus $5K from 1 others
What the payments were for
- Food & beverage$71189%
- Education$9011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 5 | $215 |
| AstraZeneca | 7 | $140 |
| Astellas Pharma US Inc | 1 | $90 |
| Amgen | 4 | $78 |
| Novo Nordisk | 3 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Johnson & Johnson | 2 | $30 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Merck | 1 | $23 |
| Exact Sciences | 1 | $20 |
| Pfizer | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$149
How this compares
$801 in reported general payments places this provider in the 75th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alcohol Prep PadsAlcohol Antiseptic Pads | 23 | $897 |
| Clonazepam | 31 | $195 |
| Temazepam | 26 | $155 |
| Alprazolam | 30 | $128 |
Paid to pharmacies, not to this prescriber.
Other general practice in Miami
- Idalia AcostaMiami$99K
- Eddie GomezMiami$59K
- Aladino ValienteMiami$24K
- Viviana WaichMiami$20K
- Libia RiosMiami$15K
- Jose CardonaMiami$15K
- Rosa HuguetMiami$15K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.